Aksnes, Mari http://orcid.org/0000-0002-7595-527X
Aass, Hans Christian D.
Tiiman, Ann
Edwin, Trine Holt
Terenius, Lars
Bogdanović, Nenad
Vukojević, Vladana
Knapskog, Anne-Brita
Funding for this research was provided by:
Olav Thon Stiftelsen
Nasjonalforeningen for Folkehelsen
Stiftelsen för Strategisk Forskning (SBE13-0115)
Vetenskapsrådet (VR 2018-05337)
Stiftelsen Olle Engkvist Byggmästare (199-0480)
Magnus Bergvalls Stiftelse (2018-02642)
Region Stockholm (ALF project 20180365, ALF project 20190561)
Article History
Received: 30 March 2021
Accepted: 27 May 2021
First Online: 8 June 2021
Declarations
:
: All patients and their family caregivers gave their informed, written consent for participation. This study was approved by the Norwegian Regional Committees for Medical and Health Research Ethics (REC South East, 2017/2235 and 2017/371) and the Data Protector Officer at Oslo University Hospital.
: Not applicable.
: ABK and THE have worked on clinical trials for Roche (BN29553) and Boehringer-Ingelheim (1346.0023). AT, LT and VV have filed a patent application under the Patent Cooperation Treat (PCT): WO 2019/192969 A1 “Method for the Diagnosis of Amyloid-Associated Diseases”. HCDA, MA and NB declared they had no competing interests.